MultiCare Health System's Tacoma General Hospital is the largest hospital in Tacoma, Washington. It is a level II trauma center with 437 beds and the second largest obstetrical care center in the state of Washington. Tacoma General began serving patients in 1882.

There are 437 beds in MultiCare Tacoma General Hospital.

During the past decade, MultiCare Tacoma General Hospital conducted 129 clinical trials. In the 10-year time frame, 129 clinical trials started and 103 clinical trials were completed, i.e. on average, 79.8% percent of trials that started reached the finish line to date. In the past 5 years, 42 clinical trials started and 68 clinical trials were completed. i.e. 161.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MultiCare Tacoma General Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 73 trials, followed by "Gynecologic Oncology Group" with 41 trials sponsored, "SWOG Cancer Research Network" with 28 trials sponsored, "Alliance for Clinical Trials in Oncology" with 18 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored. Other sponsors include 80 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MultiCare Tacoma General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 121 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 65 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "MultiCare Tacoma General Hospital" are "Ovarian Cancer" (15 trials), "Primary Peritoneal Cavity Cancer" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Cervical Adenocarcinoma" (9 trials) and "Endometrial Cancer" (9 trials). Many other conditions were trialed in "MultiCare Tacoma General Hospital" in a lesser frequency.

Most popular intervention types in "MultiCare Tacoma General Hospital" are "Drug" (205 trials), "Other" (126 trials), "Biological" (72 trials), "Procedure" (41 trials) and "Radiation" (28 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (68 trials), "Quality-of-Life Assessment" (52 trials), "Paclitaxel" (34 trials), "Carboplatin" (25 trials) and "Placebo" (25 trials). Other intervention names were less common.

The vast majority of trials in "MultiCare Tacoma General Hospital" are 168 trials for "All" genders, 85 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "MultiCare Tacoma General Hospital". undefined are not yet recruiting, 33 are recruiting, 87 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 96 completed trials in MultiCare Tacoma General Hospital, 2 suspended trials, and 35 terminated clinical trials to date.

Out of the total trials that were conducted in MultiCare Tacoma General Hospital, 12 "Phase 1" clinical trials were conducted, 96 "Phase 2" clinical trials and 132 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 18 trials that are defined as “Not Applicable".

MultiCare Tacoma General Hospital has several departments that took part in Clinical trials: "MultiCare Institute for Research & Innovation" - 115 trials, "MultiCare Deaconess Cancer and Blood Specialty Center - Valley" - 108 trials, "MultiCare Deaconess Cancer and Blood Specialty Center - Downtown" - 146 trials, "MultiCare Regional Cancer Center at Tacoma General Hospital" - 67 trials, "Auburn Regional Center for Cancer Care" - 31 trials, "Tacoma Center For Arthritis Research Ps" - 15 trials, "Pulmonary Consultants" - 9 trials, "MultiCare Regional Cancer Center - Auburn" - 5 trials, "Institute for Research and Innovation | MultiCare Health System" - 4 trials, "MultiCare Neuroscience Center of Washington" - 3 trials, "Multicare Health System- Rockwood Pediatrics" - 2 trials, "Rockwood Clinic North - Pediatrics" - 2 trials